- Home
- MAIA vs FORA Comparison
MAIA vs FORA Comparison
Compare MAIA & FORA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MAIA
- FORA
- Stock Information
- Founded
- MAIA 2018
- FORA 2014
- Country
- MAIA United States
- FORA United States
- Employees
- MAIA N/A
- FORA N/A
- Industry
- MAIA Biotechnology: Pharmaceutical Preparations
- FORA Computer Software: Prepackaged Software
- Sector
- MAIA Health Care
- FORA Technology
- Exchange
- MAIA Nasdaq
- FORA Nasdaq
- Market Cap
- MAIA 65.9M
- FORA 63.8M
- IPO Year
- MAIA 2022
- FORA N/A
- Fundamental
- Price
- MAIA $2.13
- FORA $2.03
- Analyst Decision
- MAIA
- FORA Strong Buy
- Analyst Count
- MAIA 0
- FORA 1
- Target Price
- MAIA N/A
- FORA $5.00
- AVG Volume (30 Days)
- MAIA 163.9K
- FORA 18.2K
- Earning Date
- MAIA 11-12-2024
- FORA 11-13-2024
- Dividend Yield
- MAIA N/A
- FORA N/A
- EPS Growth
- MAIA N/A
- FORA N/A
- EPS
- MAIA N/A
- FORA N/A
- Revenue
- MAIA N/A
- FORA $19,709,723.00
- Revenue This Year
- MAIA N/A
- FORA N/A
- Revenue Next Year
- MAIA N/A
- FORA $10.64
- P/E Ratio
- MAIA N/A
- FORA N/A
- Revenue Growth
- MAIA N/A
- FORA 6.97
- 52 Week Low
- MAIA $0.82
- FORA $2.00
- 52 Week High
- MAIA $5.99
- FORA $4.15
- Technical
- Relative Strength Index (RSI)
- MAIA 33.62
- FORA 39.25
- Support Level
- MAIA $2.42
- FORA $2.03
- Resistance Level
- MAIA $3.48
- FORA $2.13
- Average True Range (ATR)
- MAIA 0.29
- FORA 0.08
- MACD
- MAIA -0.06
- FORA 0.00
- Stochastic Oscillator
- MAIA 1.46
- FORA 15.00
About MAIA MAIA Biotechnology Inc.
MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company. The company develops targeted immunotherapies for cancer. The company is an immune-oncology company, focused on the development of first-in-class drugs with novel mechanisms of action that are intended to meaningfully improve and extend the lives of people with cancer. The company's program is THIO, a potential cancer telomere-targeting agent in clinical development for the treatment of telomerase-positive cancer cells.
About FORA Forian Inc.
Forian Inc provides a suite of Software, data management capabilities, and proprietary data and analytics to optimize and measure operational, clinical, and financial performance for customers within the traditional and emerging life sciences, healthcare payer, and provider segments, as well as cannabis dispensaries, manufacturers, and cultivators.